Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (1,746,309) $ (987,695)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 2,089,317 1,639,104
Amortization of right-of-use assets 189,238 179,207
Amortization of debt issuance costs and debt discount 1,142,699 1,134,240
Bad debt (recovery) expense (31,875) 109,533
Loss on disposal of property & equipment 33,245  
Deferred income tax (39,388) 3,059
Stock-based compensation 540,322 716,029
Changes in operating assets and liabilities:    
Accounts receivable (1,433,623) (327,667)
Income tax receivable (5,739) 1,104,190
Prepaid expenses and other current assets 334,954 12,066
Other assets 53,766 (2,513)
Accounts payable 2,226,036 (496,874)
Accrued expenses 42,468 (2,677,583)
Revenue contract liability (166,678) 177,641
Operating lease liabilities (200,977) (183,287)
Net cash provided by operating activities 3,027,456 399,450
Cash flows from investing activities:    
Investment in internally developed software (562,247) (556,040)
Acquisition of property and equipment   (15,494)
Acquisition of assets deployed at client locations (1,722,064) (1,483,671)
Transfer of title of assets deployed at client locations to perpetual license customer 1,102,908 764,865
Net cash used in investing activities (1,181,403) (1,290,340)
Cash flows from financing activities:    
Payments of debt issuance costs   (26,897)
Proceeds from stock option exercises 56,082 67,500
Principal payments on long-term debt (704,120) (1,450,406)
Net cash used in financing activities (648,038) (1,409,803)
Effect of exchange rate changes on cash 9,656 1,252
Net increase (decrease) in cash and cash equivalents 1,207,671 (2,299,441)
Cash and cash equivalents – beginning of period 16,691,514 18,237,513
Cash and cash equivalents – end of period 17,899,185 15,938,072
Supplemental cash flow information:    
Cash paid for interest 5,762,757 5,734,663
Cash paid for income taxes 101,536 161,124
Supplemental schedule of non-cash activities:    
Insurance acquired under note payable $ 330,371 $ 378,000